✦ LIBER ✦

634 Taxotere: From preclinical to clinical pharmacology

✍ Scribed by M. Marty; J.M. Extra; C. Cuvier; M. Espie

Book ID: 116167383
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 161 KB
Volume: 31
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(95)95886-b

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A renaissance in marine pharmacology: Fr

A renaissance in marine pharmacology: From preclinical curiosity to clinical reality

✍ Keith B. Glaser; Alejandro M.S. Mayer 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 243 KB

From clinical pharmacology to clinical r

From clinical pharmacology to clinical rheumatology: bench to bedside

✍ P Pispati 📂 Article 📅 2003 🏛 BioMed Central 🌐 English ⚖ 554 KB

From Physical Pharmacy to Clinical Pharm

From Physical Pharmacy to Clinical Pharmacology

✍ Masahiro Nakano 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 8 KB

The RANKL/RANK/OPG pathway: Preclinical

The RANKL/RANK/OPG pathway: Preclinical and clinical pharmacology with relevance to GIO

✍ S. Ferrari 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Postherpetic Neuralgia: From Preclinical

Postherpetic Neuralgia: From Preclinical Models to the Clinic

✍ Ada Delaney; Lesley A. Colvin; Marie T. Fallon; Robert G. Dalziel; Rory Mitchell 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 93 KB

Postherpetic neuralgia (PHN), a common complication of herpes zoster, which results from reactivation of varicella zoster virus, is a challenging neuropathic pain syndrome. The incidence and severity of herpes zoster and PHN increases with immune impairment or age and may become a greater burden bot

Melanoma peptide vaccines: From preclini

Melanoma peptide vaccines: From preclinical background to clinical trials

✍ Jeffrey Weber 📂 Article 📅 2000 🏛 Current Science Inc. 🌐 English ⚖ 417 KB